Cowen and Company’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Cowen and Company’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,600	Closed	-$1.72K	–	742
2023 Q2	$1.72K	Hold	50,600	–	–	﹤0.01%	548
2023 Q1	$3.52K	Sell	50,600 -46,099	-48%	-$3.9K	﹤0.01%	491
2022 Q4	$2.43K	Buy	+96,699	New	+$7.74K	﹤0.01%	554
2022 Q1	–	Sell	-61,559	Closed	-$25K	–	787
2021 Q4	$25K	Buy	+61,559	New	+$42.2K	﹤0.01%	509

Other funds holding APGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Cowen and Company's APGNW Position: Q3 2023 in Review

Cowen and Company sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 50,600 shares — an estimated $1.72K sold.

Cowen and Company first reported a position in APGNW in Q4 2021 and held it in 4 quarters. The position peaked at $25K in Q4 2021. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

Cowen and Company reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Cowen and Company sold 50,600 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $1.72K.
Cowen and Company first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q4 2021 and held it in 4 quarters.
Cowen and Company's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $25K in Q4 2021.
1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Cowen and Company's 13F filing for Q3 2023, filed 9 Nov 2023.